Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Jonathan Hofmann

Pooled Investigation of Circulating Adiponectin and Multiple Myeloma and Immunoproliferative Diseases in the NCI Cohort Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Elad Ziv

Influence of germ line genetic variation on myeloma progression and survival

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Lindsay Morton

Childhood cancer survivor study (CCSS)

Sarcoma Thyroid Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Melanoma of skin Lip, oral cavity Leukaemia Larynx Kidney, renal pelvis and ureter Hodgkin lymphoma Breast Brain, nervous system

Radiation Oncology Pediatric oncology or childhood cancer

Brenda M Birmann

Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis

Multiple myeloma and immunoproliferative diseases

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

Qing Lan

A Hospital-based Case-control Study of Lymphoma in Asia (AsiaLymph)

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Laura B Freeman

Pooled Investigation of Pesticides and Lymphoma and Multiple Myeloma and Immunoproliferative Diseases in NCI and Cross-Canada Case-Control Studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Robert Zygmunt Orlowski

Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma

Multiple myeloma and immunoproliferative diseases

Robert Hoover

Nordic Countries Linked Medical Birth and Cancer Registries Project

Multiple myeloma and immunoproliferative diseases Breast